Welcome to our dedicated page for Clarivate Plc SEC filings (Ticker: CLVT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Clarivate Plc filings document the financial reporting, governance and capital structure of a Jersey-incorporated public company that provides enriched data, analytics, workflow solutions and expert services across Academia & Government, Intellectual Property, and Life Sciences & Healthcare. Current reports furnish quarterly and annual earnings releases, supplemental revenue, earnings and guidance materials, and Regulation FD presentations.
The company's SEC records also cover proxy governance and executive compensation matters, including annual meeting disclosures and executive severance plan terms. Other filings describe financing arrangements involving subsidiaries, credit agreement amendments, senior secured note redemption and satisfaction and discharge, and related material-event disclosures under the Exchange Act.
Mourad Maroun S., a director and President, IP at Clarivate plc (CLVT), reported ownership of 105,000 ordinary shares held indirectly through his spouse. The Form 3 reflects an event dated 09/08/2025 and the filing bears a signature by an attorney-in-fact dated 09/16/2025. No derivative securities or additional holdings are disclosed.
Clarivate Plc (CLVT) submitted a Form 144 notice for a proposed sale of 100,000 common shares. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value reported as $426,370.00 and approximately 672,219,064 shares outstanding. The filer indicates these were acquired as restricted stock from the issuer on 08/13/2025 and payment was recorded the same day. An earlier sale of 100,000 common shares by the same person on 07/01/2025 generated gross proceeds of $453,000.00. The notice includes the required representation that the seller is unaware of undisclosed material adverse information.
Clarivate Plc director and officer Henry Levy reported a withholding of 70,746 ordinary shares on 08/13/2025 to satisfy taxes arising from the vesting of restricted share units; the withholding price per share was $4.26. After this withholding disposition, Mr. Levy beneficially owns 679,920 ordinary shares directly. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 08/15/2025. The filing identifies the transaction code F, and explicitly states the shares were withheld for taxes upon RSU vesting.
Clarivate PLC (CLVT) insider Shem Tov Matitiahu S., listed as Chief Executive Officer and Director, reported a transaction dated 08/13/2025. The filing shows 90,662 ordinary shares were disposed at a reported price of $4.26. After the transaction the reporting person beneficially owned 1,331,811 shares directly and 320,603 shares indirectly through IBI Trust Management. The form states the 90,662 shares were withheld for taxes upon vesting of restricted share units, indicating the disposition related to tax withholding rather than an open-market sale.
Clarivate Plc insider transaction by William E. Graff: The filing reports a non-derivative disposition of 23,525 ordinary shares on 08/13/2025 at a price of $4.26 per share. The form states these shares were withheld to satisfy taxes upon the vesting of restricted share units. After the reported transaction, Mr. Graff beneficially owns 615,146 ordinary shares, held directly. The Form 4 was signed by an attorney-in-fact on 08/15/2025. No derivative transactions or other changes in indirect ownership are reported. The filing documents an internal tax-withholding sale tied to equity compensation rather than an open-market purchase or a standalone sale for liquidity.
Samson James Gordon, listed as an officer (President, IP) and director of Clarivate PLC (CLVT), reported a non-sale disposition on 08/13/2025 where 22,581 ordinary shares were withheld for taxes upon the vesting of restricted share units at a price of $4.26 per share. After this tax withholding, Mr. Gordon beneficially owned 1,248,522 ordinary shares directly. The Form 4 was executed by an attorney-in-fact on behalf of the reporting person.
Clarivate PLC insider transactions by Jonathan Mark Collins show two non-derivative disposals in August 2025. On 08/13/2025 he had 140,645 ordinary shares withheld to cover taxes on vested restricted share units at a reported price of $4.26, leaving him with 825,434 shares directly beneficially owned after that transaction. On 08/15/2025 a second disposal of 48,387 ordinary shares was reported at $0, reducing his direct ownership to 777,047 shares. The filing lists Collins as Executive Vice President/CFO and a director and is filed individually.
The 48,387-share transfer is described as occurring pursuant to a divorce settlement and was made for no consideration; the filing notes Collins no longer reports beneficial ownership of shares owned by his former spouse. The Form 4 is signed by an attorney-in-fact on 08/15/2025.